Dhaka, Bangladesh (BBN) - GlaxoSmithKline (GSK) Bangladesh has recommended 500 per cent cash dividend for the year ended on December 31, 2016, said an official disclosure on Sunday.
The Board of Directors of final approval of this dividend will come during the annual general meeting (AGM) scheduled to be held on April 20 at 11:00am at Hotel Agrabad in Chittagong.
The record date for entitlement of dividend is on March 23, 2017.
The multinational company has also reported earnings per share (EPS) of BDT 53.51, net asset value (NAV) per share of BDT 214.65 and net operating cash flow per share (NOCFPS) of BDT 71.86 for the year ended on December 31, 2016 as against BDT 68.99, BDT 216.15 and BDT 84.42 respectively for the same period of the previous year.
There will be no price limit on the trading of the shares of the company today following its corporate declaration.
Each share price of the company, which was listed on the Dhaka bourse in 1976, closed at BDT 1,557.50 on Thursday.
The company disbursed 550 per cent cash dividend the year ended on December 31, 2015.
The company’s paid-up capital is BDT 120.46 million and authorised capital is also BDT 200 million, while the total number of securities is 12,046,449.
The sponsor-directors own 81.98 per cent stake in GlaxoSmithKline, while institutional investors 17.07 percent, and the general public only 0.95 per cent as on January 31, 2017, the DSE data shows.
BBN/SK/AD